|
⚲
|
| Keyboard |
| Curran Daniel J
✚
|
|
|---|---|
| CIK # | 0001887599 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001887599] | |
| 4 | [0001887599] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Xilio Therapeutics Inc | |
| Curran Daniel J | |
| ALX Oncology Holdings Inc | |
| Catalyst Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ALX Oncology Holdings Inc ALXO
Stock Option (right to buy) · derivative
|
2026-01-20 | Grant | 16,833 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2025-11-20 | Grant | 18,115 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-11-20 | Grant | 5,468 | $0.00 | |
|
ALX Oncology Holdings Inc ALXO
Stock option (right to buy) · derivative
|
2025-08-12 | Grant | 40,400 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Stock Option (right to buy) · derivative
|
2025-06-11 | Grant | 31,000 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Stock Option (right to buy) · derivative
|
2024-06-14 | Grant | 25,000 | $0.00 |